Celanese Corp. (CE) –
-
Celanese Corp. (CE) Appoints Kim K.W. Rucker to its Board
-
Celanese Announces Kim K.W. Rucker as New Lead Independent Director
-
Celanese to Hold First Quarter Earnings Conference Call on May 9, 2024
-
Celanese Corp. (CE) Declares $0.70 Quarterly Dividend; 1.8% Yield
-
Celanese Corporation Declares Quarterly Dividend of $0.70 Per Share
-
Chemical Marketing & Economics Honors Celanese Chairman, CEO and President Lori J. Ryerkerk with STEM Leadership Award for Corporate Reinvention
-
Celanese (CE) PT Lowered to $135 at BofA Securities
-
Celanese (CE) PT Raised to $167 at Citi
-
Celanese Completes Series of Strategic Actions Across its Global Acetyl Chain
-
Celanese (CE) PT Raised to $190 at KeyBanc
-
Celanese (CE) PT Raised to $199 at UBS
-
Barclays Downgrades Celanese (CE) to Equalweight
-
JPMorgan Downgrades Celanese (CE) to Underweight, 'reflecting 2026 earnings and then some, which may limit capital appreciation potential'
-
Celanese (CE) PT Raised to $195 at Wells Fargo
-
Form ARS Celanese Corp For: Dec 31
-
Form DEFA14A Celanese Corp
-
Form DEF 14A Celanese Corp For: May 13
-
Celanese Achieves ISCC CFC Certification for Low Carbon CCU Methanol
-
Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies
-
Celanese Corp. (CE) and Secarna Pharmaceuticals Enter RNA Research Collaboration for Long-Acting Antisense Therapies
-
Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies
-
Form 4 Celanese Corp For: Mar 14 Filed by: Kelly Thomas Francis
-
Form 4 Celanese Corp For: Mar 14 Filed by: Richardson Scott A
-
Gimme Credit upgrades Celanese (CE) to Improving as it will 'benefit from material self-help measures'
-
Form 144 Celanese Corp Filed by: Richardson Scott A
-
Form 8-K Celanese Corp For: Mar 12
-
Form 144 Celanese Corp Filed by: Richardson Scott A
-
Form 4 Celanese Corp For: Mar 08 Filed by: Murray Mark Christopher
-
Form PRE 14A Celanese Corp For: May 13
-
Form 4 Celanese Corp For: Mar 05 Filed by: Rucker Kim K.W.
-
Form 4 Celanese Corp For: Mar 05 Filed by: Kissire Deborah J.
-
Form 4 Celanese Corp For: Mar 05 Filed by: IHLENFELD JAY V
-
Form 4 Celanese Corp For: Mar 05 Filed by: Hill Kathryn
-
Form 4 Celanese Corp For: Mar 05 Filed by: GALANTE EDWARD G
-
Form 4 Celanese Corp For: Mar 05 Filed by: Brown William M
-
Form 4 Celanese Corp For: Mar 05 Filed by: BLACKWELL JEAN S
-
Form 4 Celanese Corp For: Feb 28 Filed by: Ryerkerk Lori
-
Form 4 Celanese Corp For: Feb 28 Filed by: Richardson Scott A
-
Form 4 Celanese Corp For: Feb 28 Filed by: Murray Mark Christopher
-
Form 4 Celanese Corp For: Feb 28 Filed by: McGilvray Aaron M
-
Form 4 Celanese Corp For: Feb 28 Filed by: Kelly Thomas Francis
-
Form 4 Celanese Corp For: Feb 28 Filed by: Kyrish Chuck
-
Form 4 Celanese Corp For: Feb 28 Filed by: Duffie Ashley B
-
Form 8-K Celanese Corp For: Feb 29
-
Form 3 Celanese Corp For: Feb 28 Filed by: Go Timothy
-
Celanese (CE) Announces Commercial Launch of Glaukos' iDose TR Using Celanese's VitalDose Ethylene Vinyl Acetate
-
Celanese Announces Commercial Launch of Glaukos' iDoseĀ® TR (Travoprost Intracameral Implant) Using Celanese's VitalDoseĀ® Ethylene Vinyl Acetate (EVA)
-
Form 8-K Celanese Corp For: Feb 27
-
Celanese (CE) Appoints Timothy Go to its Board
-
Timothy Go Elected to Celanese Board of Directors
Back to CE Stock Lookup